INTERACTION OF ETHANOL WITH HEPATIC MICROSOMES
INTERACTION OF ETHANOL WITH HEPATIC MICROSOMES
批准号:
3109214
负责人:
CHARLES S LIEBER
金额:
$10.61万
依托单位国家:
美国
项目类别:
财政年份:
1983
资助国家:
美国
项目状态:
已结题
起止时间:
1983-07-01 至 1988-06-30
关键词:
alcoholic beverage consumption biochemistry chemical carcinogen chemical structure cytochrome P450 drug adverse effect drug tolerance ethanol free radicals hepatotoxin hydroxyl group lipid peroxides liver cells liver metabolism microsomes nutrition related tag oxidation radiotracer retinoate species difference steroid hormone metabolism vitamin A deficiency vitamin metabolism vitamins
中文摘要
点击翻译按钮获取中文摘要
英文摘要
After having established the microsomal ethanol oxidizing system (MEOS) as
an entity distinct from alcohol dehydrogenase (ADH) and catalase, the
applicant now wishes to address the question of the mechanism involved and
the role of MEOS in ethanol metabolism in vitro and in vivo. Specifically,
the ethanol-induced form of cytochrome P-450 will be purified from rats,
deermice and baboons. We will characterize the purified protein(s) in
terms of molecular weight, spectra, substrate specificity and peptide
mapping. Despite known differences in the cytochrome P-450 of these
species, we hope to find a common change that may shed some light on the
nature of the ethanol-induced alteration and its specificity for ethanol as
a substrate. We will also determine to what extent hydroxyl radicals are
involved in ethanol oxidation mediated by the ethanol-induced form of
cytochrome P-450. Furthermore, we will assess whether the changes in
cytochrome P-450 result in altered metabolism of other substrates such as
steroid hormones and retinoic acid (a form of vitamin A of significance for
the nutritional status of the alcoholic), carcinogens (of possible
importance for the enhanced incidence of cancers in the alcoholic) and in
enhanced hepatotoxicity of industrial solvents and commonly used drugs,
including promotion of lipid peroxidation (of relevance to the pathogenesis
of alcoholic liver injury). To assess the relative importance of MEOS and
to determine how much it contributes to the metabolic tolerance that
develops after chronic ethanol consumption, we will compare the fate of
(3H) xylitol and (H3) ethanol in hepatocytes isolated from ADH+ and ADH-
deermice. In the same experimental model we will study the isotope effect
of deuterium to differentiate MEOS from the other alcohol oxidizing
systems, both in isolated hepatocytes and in vivo. The broad aim of our
study is to contribute to our understanding of how alcoholics differ from
non-alcoholics in biochemical terms; specifically we plan to determine to
what extent changes produced in the microsomal cytochrome P-450 by alcohol
consumption alters the response of the alcoholic to endogenous and
exogenous compounds in a way that may affect alcohol induced liver
pathology, its prevention and its treatment.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Liver Fibrosis, Inflammation & Oxidative Stress Markers
-
批准号:6770660
-
项目类别:
-
资助金额:$12.3万
-
财政年份:2004
-
负责人:CHARLES S LIEBER
-
依托单位:
Liver Fibrosis, Inflammation & Oxidative Stress Markers
-
批准号:7101927
-
项目类别:
-
资助金额:$12.01万
-
财政年份:2004
-
负责人:CHARLES S LIEBER
-
依托单位:
Synergistic Nutraceutical Effects of DLPC and SAMe
-
批准号:7024566
-
项目类别:
-
资助金额:$27.82万
-
财政年份:2004
-
负责人:CHARLES S LIEBER
-
依托单位:
Synergistic Nutraceutical Effects of DLPC and SAMe
-
批准号:6770613
-
项目类别:
-
资助金额:$28.49万
-
财政年份:2004
-
负责人:CHARLES S LIEBER
-
依托单位:
Liver Fibrosis, Inflammation & Oxidative Stress Markers
-
批准号:6952293
-
项目类别:
-
资助金额:$12.3万
-
财政年份:2004
-
负责人:CHARLES S LIEBER
-
依托单位:
Synergistic Nutraceutical Effects of DLPC and SAMe
-
批准号:7204192
-
项目类别:
-
资助金额:$27.66万
-
财政年份:2004
-
负责人:CHARLES S LIEBER
-
依托单位:
Synergistic Nutraceutical Effects of DLPC and SAMe
-
批准号:6884085
-
项目类别:
-
资助金额:$28.49万
-
财政年份:2004
-
负责人:CHARLES S LIEBER
-
依托单位:
ANTIVIRAL & ANTIFIBROTIC LIVER THERAPY OF HCV+ DRINKERS
-
批准号:6211435
-
项目类别:
-
资助金额:$50.5万
-
财政年份:2000
-
负责人:CHARLES S LIEBER
-
依托单位:
Antiviral/Antifibrotic Liver Therapy of HCV+ Drinkers
-
批准号:7046265
-
项目类别:
-
资助金额:$15.9万
-
财政年份:2000
-
负责人:CHARLES S LIEBER
-
依托单位:
ANTIVIRAL & ANTIFIBROTIC LIVER THERAPY OF HCV+ DRINKERS
-
批准号:7064573
-
项目类别:
-
资助金额:$5.84万
-
财政年份:2000
-
负责人:CHARLES S LIEBER
-
依托单位:
ANTIVIRAL & ANTIFIBROTIC LIVER THERAPY OF HCV+ DRINKERS
-
批准号:6757147
-
项目类别:
-
资助金额:$4.66万
-
财政年份:2000
-
负责人:CHARLES S LIEBER
-
依托单位:
ANTIVIRAL & ANTIFIBROTIC LIVER THERAPY OF HCV+ DRINKERS
-
批准号:6754514
-
项目类别:
-
资助金额:$57.17万
-
财政年份:2000
-
负责人:CHARLES S LIEBER
-
依托单位:
ANTIVIRAL & ANTIFIBROTIC LIVER THERAPY OF HCV+ DRINKERS
-
批准号:6629687
-
项目类别:
-
资助金额:$50.97万
-
财政年份:2000
-
负责人:CHARLES S LIEBER
-
依托单位:
Antiviral/Antifibrotic Liver Therapy of Hepatitis C positive Alcohol Drinkers
-
批准号:7174853
-
项目类别:
-
资助金额:$3.89万
-
财政年份:2000
-
负责人:CHARLES S LIEBER
-
依托单位:
ANTIVIRAL & ANTIFIBROTIC LIVER THERAPY OF HCV+ DRINKERS
-
批准号:6371842
-
项目类别:
-
资助金额:$48.05万
-
财政年份:2000
-
负责人:CHARLES S LIEBER
-
依托单位:
ANTIVIRAL & ANTIFIBROTIC LIVER THERAPY OF HCV+ DRINKERS
-
批准号:6509403
-
项目类别:
-
资助金额:$49.49万
-
财政年份:2000
-
负责人:CHARLES S LIEBER
-
依托单位:
DLPC Treatment of Alcoholic and Non-Alcoholic Fibrosis
-
批准号:6730471
-
项目类别:
-
资助金额:$4.73万
-
财政年份:1996
-
负责人:CHARLES S LIEBER
-
依托单位:
DLPC TREATMENT OF ALCOHOLIC AND NON ALCOHOLIC FIBROSIS
-
批准号:2356822
-
项目类别:
-
资助金额:$19.11万
-
财政年份:1996
-
负责人:CHARLES S LIEBER
-
依托单位:
DLPC Treatment of Alcoholic and Non-Alcoholic Fibrosis
-
批准号:6430585
-
项目类别:
-
资助金额:$26.16万
-
财政年份:1996
-
负责人:CHARLES S LIEBER
-
依托单位:
DLPC TREATMENT OF ALCOHOLIC AND NON ALCOHOLIC FIBROSIS
-
批准号:6168329
-
项目类别:
-
资助金额:$22.36万
-
财政年份:1996
-
负责人:CHARLES S LIEBER
-
依托单位:
海外基金